{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:53:54Z","timestamp":1790564034853,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T00:00:00Z","timestamp":1573344000000},"content-version":"vor","delay-in-days":2019,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1093\/annonc\/mdt538","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T01:41:06Z","timestamp":1390268466000},"page":"927-935","source":"Crossref","is-referenced-by-count":78,"title":["Cervical cancer screening: on the way to a shift from cytology to full molecular screening"],"prefix":"10.1016","volume":"25","author":[{"given":"M.G.","family":"Dijkstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.F.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"Rijkaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.L.M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdt538_bb0010","series-title":"WHO\/ICO information centre on HPV and cervical cancer (HPV Information Centre). Human papillomavirus and related cancers in World","author":"IARC","year":"2010"},{"key":"10.1093\/annonc\/mdt538_bb0015","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","article-title":"Worldwide burden of cervical cancer in 2008","volume":"22","author":"Arbyn","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer epidemic that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt538_bb0025","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/ijc.25553","article-title":"Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?","volume":"128","author":"de","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1018435522475","article-title":"International incidence rates of invasive cervical cancer after introduction of cytological screening","volume":"8","author":"Gustafsson","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1093\/annonc\/mdt538_bb0035","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","article-title":"Trends of cervical cancer mortality in the member states of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0040","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0045","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdt538_bb0050","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/oxfordjournals.aje.a117485","article-title":"Meta-analysis of Pap test accuracy","volume":"141","author":"Fahey","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1093\/annonc\/mdt538_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1470-2045(11)70334-5","article-title":"How might HPV testing be integrated into cervical screening?","volume":"13","author":"Katki","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0060","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/ijc.20678","article-title":"Cervical cancer in the Netherlands 1989\u20131998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women","volume":"113","author":"Bulk","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N","article-title":"Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963\u20131995: recent increase in cervical cancer incidence","volume":"83","author":"Anttila","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/mdt538_bb0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0080","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Munoz","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsague","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt538_bb0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.bjc.6605758","article-title":"Monitoring HPV16\/18 immunisation in England and elsewhere","volume":"103","author":"Franceschi","year":"2010","journal-title":"Br J Cancer"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdt538_bb0095","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ypmed.2011.08.015","article-title":"Adolescent and young adult HPV vaccination in Australia: achievements and challenges","volume":"53","author":"Garland","year":"2011","journal-title":"Prev Med"},{"key":"10.1093\/annonc\/mdt538_bb0100","first-page":"1","article-title":"HPV vaccination: understanding the impact on HPV disease","volume":"34","author":"Shearer","year":"2011","journal-title":"Purple Papers"},{"key":"10.1093\/annonc\/mdt538_bb0105","unstructured":"EA van Lier. Immunization coverage National Immunization programme in The NetherlandsRIVM report 210021014\/2011. 1-1-2011. Ref Type: Report."},{"key":"10.1093\/annonc\/mdt538_bb0110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1059840511415861","article-title":"The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature","volume":"27","author":"Bartlett","year":"2011","journal-title":"J Sch Nurs"},{"key":"10.1093\/annonc\/mdt538_bb0115","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease","volume":"131","author":"Arbyn","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/GCO.0b013e3283567005","article-title":"Human papillomavirus vaccine in adolescent women: a 2012 update","volume":"24","author":"Etter","year":"2012","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1093\/annonc\/mdt538_bb0125","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt538_bb0130","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0135","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdt538_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"101","author":"Naucler","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt538_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0150","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdt538_bb0155","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/ijc.23339","article-title":"Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology\u2014results from the Hammersmith study","volume":"122","author":"Cuzick","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1470-2045(09)70296-7","article-title":"Trials comparing cytology with human papillomavirus screening","volume":"10","author":"Arbyn","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0165","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1470-2045(09)70246-3","article-title":"Further analysis of the ARTISTIC trial","volume":"10","author":"Sasieni","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0175","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mdt538_bb0180","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0185","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. The International HPV screening working group. Lancet. 2013 November 1. doi:pii: S0140-6736(13)62218-7. 10.1016\/S0140-6736(13)62218-7. [epub ahead of print]."},{"key":"10.1093\/annonc\/mdt538_bb0190","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.25211","article-title":"The health and economic effects of HPV DNA screening in The Netherlands","volume":"127","author":"Berkhof","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0195","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/bjc.2011.581","article-title":"HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications","volume":"106","author":"Rijkaart","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0200","article-title":"Primary hrHPV DNA testing in cervical cancer screening: how to manage screen positive women? A POBASCAM trial substudy","author":"Dijkstra","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mdt538_bb0205","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1093\/annonc\/mdt538_bb0210","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdt538_bb0215","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdt538_bb0220","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1128\/JCM.00476-08","article-title":"Comparison of GP5+\/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia","volume":"46","author":"Hesselink","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1093\/annonc\/mdt538_bb0225","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"issue":"Suppl 3","key":"10.1093\/annonc\/mdt538_bb0230","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(09)00540-X","article-title":"Validation of high-risk HPV tests for primary cervical screening","volume":"46","author":"Meijer","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1093\/annonc\/mdt538_bb0235","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/JCM.00725-09","article-title":"Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping","volume":"47","author":"Castle","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1093\/annonc\/mdt538_bb0240","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1600-0463.2010.02621.x","article-title":"Methods for HPV detection in exfoliated cell and tissue specimens","volume":"118","author":"Snijders","year":"2010","journal-title":"APMIS"},{"key":"10.1093\/annonc\/mdt538_bb0245","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/JCM.01743-09","article-title":"Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+\/6+-PCR-enzyme immunoassay in population-based cervical screening","volume":"48","author":"Hesselink","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1093\/annonc\/mdt538_bb0250","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1128\/JCM.05552-11","article-title":"Clinical validation of the cobas 4800 HPV test for cervical screening purposes","volume":"49","author":"Heideman","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1093\/annonc\/mdt538_bb0255","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1128\/JCM.02311-10","article-title":"Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting","volume":"49","author":"Carozzi","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mdt538_bb0260","doi-asserted-by":"crossref","first-page":"F100","DOI":"10.1016\/j.vaccine.2012.04.105","article-title":"Nucleic acid tests for the detection of alpha human papillomaviruses","volume":"30","author":"Poljak","year":"2012","journal-title":"Vaccine"},{"key":"10.1093\/annonc\/mdt538_bb0265","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/JCM.00633-13","article-title":"Clinical validation of the Abbott RealTime High Risk (HR) HPV assay according to the guidelines for HPV DNA test requirements for cervical screening","volume":"51","author":"Hesselink","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdt538_bb0270","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S1386-6532(09)70008-3","article-title":"Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets","volume":"45","author":"Getman","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1093\/annonc\/mdt538_bb0275","first-page":"1411","article-title":"Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I","volume":"20","author":"Wu","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0280","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study","volume":"129","author":"Monsonego","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0285","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/JCM.01517-13","article-title":"The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening","volume":"51","author":"Heideman","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1093\/annonc\/mdt538_bb0290","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"Cuzick","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0295","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1093\/annonc\/mdt538_bb0300","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0310","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt538_bb0315","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0320","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrclinonc.2012.161","article-title":"Screening: cervical cancer\u2014should we abandon cytology for screening?","volume":"9","author":"Meijer","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0325","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0959-8049(02)00462-8","article-title":"New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections","volume":"38","author":"von Knebel","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0330","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1128\/JVI.75.16.7712-7716.2001","article-title":"Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes","volume":"75","author":"Duensing","year":"2001","journal-title":"J Virol"},{"key":"10.1093\/annonc\/mdt538_bb0335","first-page":"7075","article-title":"The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability","volume":"62","author":"Duensing","year":"2002","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt538_bb0340","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jmv.20153","article-title":"Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction","volume":"74","author":"Sotlar","year":"2004","journal-title":"J Med Virol"},{"key":"10.1093\/annonc\/mdt538_bb0345","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jviromet.2007.01.036","article-title":"PreTect HPV-Proofer: real-time detection and typing of E6\/E7 mRNA from carcinogenic human papillomaviruses","volume":"142","author":"Molden","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1093\/annonc\/mdt538_bb0350","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/JCM.06587-11","article-title":"High-risk human papillomavirus (hrHPV) E6\/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology","volume":"50","author":"Rijkaart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1093\/annonc\/mdt538_bb0355","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","article-title":"Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri","volume":"92","author":"Klaes","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0360","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.93.9.4350","article-title":"Inhibition of cyclin D-CDK4\/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity","volume":"93","author":"Khleif","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdt538_bb0365","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1073\/pnas.1009933108","article-title":"Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming","volume":"108","author":"McLaughlin-Drubin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdt538_bb0370","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1309\/0DGGQBDQAMJCJBXB","article-title":"The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia","volume":"122","author":"Guo","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdt538_bb0375","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygyno.2004.11.034","article-title":"Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies","volume":"97","author":"Nieh","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0380","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cncr.20046","article-title":"Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials","volume":"102","author":"Yoshida","year":"2004","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0385","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(08)70208-0","article-title":"Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial","volume":"9","author":"Carozzi","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0390","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1309\/AJCP3CD9YKYFJDQL","article-title":"The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results","volume":"134","author":"Denton","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdt538_bb0395","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1470-2045(12)70529-6","article-title":"Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial","volume":"14","author":"Carozzi","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0400","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdt538_bb0405","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cncr.21378","article-title":"Evaluation of a nuclear score for p16(INK4a)-stained cervical squamous cells in liquid-based cytology samples","volume":"105","author":"Wentzensen","year":"2005","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0410","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.20140","article-title":"p16\/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study","volume":"119","author":"Schmidt","year":"2011","journal-title":"Cancer Cytopathol"},{"key":"10.1093\/annonc\/mdt538_bb0415","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population","volume":"18","author":"Wentzensen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdt538_bb0420","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 Dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2013.01.018","article-title":"Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities","author":"Mesher","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0430","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdt538_bb0435","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604055","article-title":"Sequential gene promoter methylation during HPV-induced cervical carcinogenesis","volume":"97","author":"Henken","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0440","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/jnci\/djh031","article-title":"TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia","volume":"96","author":"Steenbergen","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt538_bb0445","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdt538_bb0450","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ijc.28138","article-title":"CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease","volume":"133","author":"Bierkens","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0455","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-10-2548","article-title":"Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women","volume":"17","author":"Hesselink","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdt538_bb0460","unstructured":"Dijkstra. Long-term CIN3+ risks following primary hrHPV DNA and triage testing in Cervical Cancer screening. submitted"},{"key":"10.1093\/annonc\/mdt538_bb0465","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ijc.22484","article-title":"Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs","volume":"120","author":"Bais","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0470","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1309\/97JHG6GLY69BVF4Y","article-title":"Frequency and outcome of cervical cancer prevention failures in the United States","volume":"128","author":"Raab","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdt538_bb0475","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.bjc.6600974","article-title":"Benefit of cervical screening at different ages: evidence from the UK audit of screening histories","volume":"89","author":"Sasieni","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0480","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ygyno.2007.01.023","article-title":"Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis","volume":"105","author":"Petignat","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0485","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/JCM.02440-05","article-title":"High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush","volume":"44","author":"Brink","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1093\/annonc\/mdt538_bb0490","doi-asserted-by":"crossref","first-page":"c1040","DOI":"10.1136\/bmj.c1040","article-title":"HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study","volume":"340","author":"Gok","year":"2010","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mdt538_bb0495","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1158\/1055-9965.EPI-11-0307","article-title":"Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial","volume":"20","author":"Virtanen","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdt538_bb0500","first-page":"2223","article-title":"High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening","volume":"32","author":"Snijders","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0505","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijgo.2006.07.012","article-title":"Primary screening for cervical cancer through self sampling","volume":"95","author":"Holanda","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1093\/annonc\/mdt538_bb0510","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":"A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China","volume":"9","author":"Qiao","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0515","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0140-6736(11)61522-5","article-title":"Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial","volume":"378","author":"Lazcano-Ponce","year":"2011","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt538_bb0520","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/sti.2004.011858","article-title":"Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis","volume":"81","author":"Ogilvie","year":"2005","journal-title":"Sex Transm Infect"},{"key":"10.1093\/annonc\/mdt538_bb0525","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/annonc\/mdh240","article-title":"Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics","volume":"15","author":"Dannecker","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0530","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1525-1438.2006.00835.x","article-title":"Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens","volume":"17","author":"Khanna","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0535","first-page":"1394","article-title":"Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types","volume":"11","author":"Castle","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdt538_bb0540","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ygyno.2005.02.001","article-title":"Comparison of type-specific human papillomavirus data from self and clinician directed sampling","volume":"97","author":"Baldwin","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0545","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jcp.55.6.435","article-title":"Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women","volume":"55","author":"Nobbenhuis","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1093\/annonc\/mdt538_bb0550","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0555","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","article-title":"HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial","volume":"95","author":"Kitchener","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt538_bb0560","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt538_bb0565","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/djn065","article-title":"Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test","volume":"100","author":"Ronco","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt538_bb0570","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/jnci\/djp367","article-title":"Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting","volume":"101","author":"Leinonen","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt538_bb0575","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/rmv.686","article-title":"The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening","volume":"21","author":"Schmeink","year":"2011","journal-title":"Rev Med Virol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419347696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419347696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/25\/5\/927\/366822\/mdt538.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:35:28Z","timestamp":1624520128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419347696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":114,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0923753419347696"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdt538","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}